References
- Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–133.
- Chen AK, Lin RY, Hsieh EZ, et al. Induction of amyloid fibrils by the C-terminal fragments of TDP-43 in amyotrophic lateral sclerosis. J Am Chem Soc. 2010;132:1186–1187.
- Liu GC, Chen BP, Ye NT, et al. Delineating the membrane-disrupting and seeding properties of the TDP-43 amyloidogenic core. Chem Commun (Camb). 2013;49:11212–11214.
- Sun CS, Wang CY, Chen BP, et al. The influence of pathological mutations and proline substitutions in TDP-43 glycine-rich peptides on its amyloid properties and cellular toxicity. PLoS One. 2014;9:e103644.
- Chen CH, Khan A, Huang JJ, et al. Mechanisms of membrane pore formation by amyloidogenic peptides in amyotrophic lateral sclerosis. Chemistry. 2016;22:9958–9961.
- He RY, Huang YC, Chiang CW, et al. Characterization and real-time imaging of the FTLD-related protein aggregation induced by amyloidogenic peptides. Chem Commun. 2015;51:8652–8655.
- He RY, Chao SH, Tsai YJ, et al. Photocontrollable probe spatiotemporally induces neurotoxic fibrillar aggregates and impairs nucleocytoplasmic trafficking. ACS Nano. 2017;11:6795–6807.